Advancements in BPDCN Treatment and Future Directions

This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix, AZ. You will hear from Anand Patel, MD, University of Chicago Medical Center, Chicago, IL, Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY, Guillermo Montalban-Bravo, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Emma Groarke, MD, National Institutes of Health, Bethesda, MD, who discuss several rare myeloid diseases, including accelerated- and blast-phase myeloproliferative neoplasms (MPN-AP/BP), blastic plasmacytoid dendritic cell neoplasm (BPDCN), chronic myelomonocytic leukemia (CMML), and VEXAS syndrome. The experts provide valuable insight into the treatment of these diseases and the unique challenges associated with each one.

The post The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS appeared first on VJHemOnc.